| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.13 | 3e-05 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-05 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | 0.49 | 0.0002 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0008 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0009 |